{"url_path":"/sec/abbv/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000017-index.html","accession_number":"0001551152-26-000017","cik":"0001551152","ticker":"ABBV","issuer_name":"AbbVie Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000017-index.html","primary_entity_key":"0001551152","primary_entity_name":"AbbVie Inc."},"word_count":187,"has_tables":true,"body_markdown":"ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS\n\n(c) Issuer Purchases of Equity Securities\n\nPeriod\n(a) Total\nNumber of\nShares \n\n(or Units)\nPurchased\n(b) Average\nPrice Paid\nper Share\n(or Unit)(c) Total Number\nof Shares (or\nUnits) Purchased\nas Part of Publicly\nAnnounced Plans\nor Programs\n\n(d) Maximum\nNumber (or\nApproximate\nDollar Value) of\nShares (or Units)\nthat May Yet Be\nPurchased Under\nthe Plans or\nPrograms\n\nJanuary 1, 2026 - January 31, 2026976 \n(1)\n$222.49\n(1)\n— $2,896,110,760\n\nFebruary 1, 2026 - February 28, 2026909 \n(1)\n$223.56\n(1)\n— $2,896,110,760\n\nMarch 1, 2026 - March 31, 20264,621,835 \n(1)\n$230.40\n(1)\n4,621,000 $1,831,437,567\n\nTotal4,623,720 \n(1)\n$230.40\n(1)\n4,621,000 $1,831,437,567\n\n1.In addition to AbbVie shares repurchased on the open market under a publicly announced program, these shares also included the shares purchased on the open market for the benefit of participants in the AbbVie Employee Stock Purchase Plan – 976 in January; 909 in February; and 835 in March.\n\nThese shares do not include the shares surrendered to AbbVie to satisfy minimum tax withholding obligations in connection with the vesting or exercise of stock-based awards."}